Early and delayed effects of naturally occurring asbestos on serum biomarkers of inflammation and metabolism

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 77, Issue 17, 2014, Pages 1024-1039

  Kodavanti, Urmila P ^a   Andrews, Debora ^a   Schladweiler, Mette C ^a   Gavett, Stephen H ^a   Dodd, Darol E ^b   Cyphert, Jaime M ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA 2 MACROGLOBULIN; AMOSITE; ASBESTOS; BIOLOGICAL MARKER; CHRYSOTILE; INSULIN; INTERLEUKIN 6; LEPTIN; MESOTHELIN; MINERAL FIBER; ONTARIO FERROACTINOLITE CLEAVAGE FRAGMENT; OROSOMUCOID; OSTEOPONTIN; TREMOLITE; TUMOR MARKER; UNCLASSIFIED DRUG; WATER;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPOSURE; INFLAMMATION; INHALATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUNG INJURY; MALE; METABOLIC SYNDROME X; METABOLISM; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

ALPHA-MACROGLOBULINS; ANIMALS; ASBESTOS; ASBESTOS, AMOSITE; ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNE SYSTEM DISEASES; INFLAMMATION; INHALATION EXPOSURE; LUNG; MALE; METABOLIC DISEASES; NEOPLASMS; OROSOMUCOID; PARTICLE SIZE; RATS; RATS, INBRED F344;

EID: 84905386738     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2014.899171     Document Type: Article

References (45)

1. Ahmad, R., Al-Mass, A., Al-Ghawas, D., Shareif, N., Zghoul, N., Melhem, M., Hasan, A., Al-Ghimlas, F., Dermime, S., and, Behbehani, K. 2013. Interaction of osteopontin with IL-18 in obese individuals: Implications for insulin resistance. PLoS One 8: e63944.
2. Aust, A. E., Cook, P. M., and, Dodson, R. F. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol. Environ. Health B 14: 40-75.
3. Bass, V., Gordon, C. J., Jarema, K. A., Macphail, R. C., Cascio, W. E., Phillips, P. M., Ledbetter, A. D., Schladweiler, M. C., Andrews, D., Miller, D., Doerfler, D. L., and, Kodavanti, U. P. 2013. Ozone induces glucose intolerance and systemic metabolic effects in young and aged brown Norway rats. Toxicol. Appl. Pharmacol. PMID: 24103449.
4. Bernstein, D. M., Rogers, R. A., Sepulveda, R., Donaldson, K., Schuler, D., Gaering, S., Kunzendorf, P., Chevalier, J., and, Holm, S. E. 2010. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: Interim results. Inhal. Toxicol. 22: 937-962.
5. Brook, R. D., and, Rajagopalan, S. 2010. Particulate matter air pollution and atherosclerosis. Curr. Atheroscler. Rep. 12: 291-300.
6. Chang, C.-C., Kuo, C.-C., Liou, S.-H., and, Yang, C.-Y. 2013. Fine particulate air pollution and hospital admissions for myocardial infarction in a subtropical city: Taipei, Taiwan. J. Toxicol. Environ. Health A 76: 440-448.
7. Chiodoni, C., Colombo, M. P., and, Sangaletti, S. 2010. Matricellular proteins: From homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 29: 295-307.
8. Chiu, H.-F., and, Yang, C.-Y. 2013. Short-term effects of fine particulate air pollution on ischemic stroke occurrence: A case-crossover study. J. Toxicol. Environ. Health A 76: 1188-1197.
9. Coffin, D. L., Palekar, L. D., and, Cook, P. M. 1982. Tumorigenesis by a ferroactinolite mineral. Toxicol. Lett. 13: 143-149.
10. Cray, C., Zaias, J., and, Altman, N. H. 2009. Acute phase response in animals: A review. Comp. Med. 59: 517-526.
11. Creaney, J., Yeoman, D., Musk, A. W., de Klerk, N., Skates, S. J., and, Robinson, B. W. 2011. Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma-Which is best? Lung Cancer 74: 55-60.
12. Cristaudo, A., Bonotti, A., Simonini, S., Vivaldi, A., Guglielmi, G., Ambrosino, N., Chella, A., Lucchi, M., Mussi, A., and, Foddis, R. 2011. Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J. Thorac. Oncol. 6: 1587-1593.
13. Cyphert, J. M., Nyska, A., Mahoney, R.K., Schladweiler, M. C., Kodavanti, U. P., and, Gavett, S. H. 2012a. Sumas Mountain chrysotile induces greater lung fibrosis in Fischer344 rats than Libby amphibole, El Dorado tremolite, and Ontario ferroactinolite. Toxicol. Sci. 130: 405-415.
14. Cyphert, J. M., Padilla-Carlin, D. J., Schladweiler, M. C., Shannahan, J. H., Nyska, A., Kodavanti, U. P., and, Gavett, S. H. 2012b. Long term response of rats to single intratracheal exposure of Libby amphibole or amosite. J. Toxicol. Environ. Health A 75: 183.-200.
15. Dipalma, N., Luisi, V., Di Serio, F., Fontana, A., Maggiolini, P., Licchelli, B., Mera, E., Bisceglia, L., Galise, I., Loizzi, M., Pizzigallo, M. A., Molinini, R., and, Vimercati, L. 2011. Biomarkers in malignant mesothelioma: Diagnostic and prognostic role of soluble mesothelin-related peptide. Int. J. Biol. Markers 26: 160-165.
16. Dulloo, A. G., and, Montani, J. P. 2012. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: An overview. Obes. Rev. 13 (. suppl 2): 1-5.
17. Ferro Zebedeo, C. N., Davis, C., Ng, K. W., and Pfau, J. C. 2013. Amphibole, but not chrysotile, asbestos induces anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J. Immunotoxicol. http://www.ncbi.nlm.nih.gov/pubmed/ 24164284.
18. Gunnarsson, P., Levander, L., Påhlsson, P., and, Grenegård, M. 2009. Alpha(1)-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway. Thromb. Haemost. 102: 694-703.
19. Kao, S. C., Reid, G., van Zandwijk, N., Henderson, D. W., and, Klebe, S. 2011. Molecular biomarkers in malignant mesothelioma: State of the art. Pathology 43: 201-212.
20. Kodavanti, U. P., Thomas, R., Ledbetter, A. D., Schladweiler, M. C., Shannahan, J. H., Wallenborn, J. G., Lund, A. K., Campen, M. J., Butler, E. O., Gottipolu, R. R., Nyska, A., Richards, J. E., Andrews, D., Jaskot, R. H., McKee, J., and, Parinandi, N. L. 2011. Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ. Health Perspect. 119: 312-318.
21. Larson, T. C., Antao, V. C., Bove, F. J., and, Cusack, C. 2012. Association between cumulative fiber exposure and respiratory outcomes among Libby vermiculite workers. J. Occup. Environ. Med. 54: 56-63.
22. Lee, Y. S., Choi, J. W., Hwang, I., Lee, J. W., Lee, J. H., Kim, A. Y., Huh, J. Y., Koh, Y. J., Koh, G. Y., Son, H. J., Masuzaki, H., Hotta, K., Alfadda, A. A., and, Kim, J. B. 2010. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J. Biol. Chem. 285: 22174-22185.
23. Leivo-Korpela, S., Lehtimäki, L., Nieminen, R., Oksa, P., Vierikko, T., Järvenpää, R., Uitti, J., and, Moilanen, E. 2012. Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers. Respir. Med. 106: 1435-1440.
24. Lindner, I., Hemdan, N.Y., Buchold, M., Huse, K., Bigl, M., Oerlecke, I., Ricken, A., Gaunitz, F., Sack, U., Naumann, A., Hollborn, M., Thal, D., Gebhardt, R., and, Birkenmeier, G. 2010. Alpha2-macroglobulin inhibits the malignant properties of astrocytoma cells by impeding beta-catenin signaling. Cancer Res. 70: 277-287.
25. Liu, G., Cheresh, P., and, Kamp, D. W. 2013. Molecular basis of asbestos-induced lung disease. Annu. Rev. Pathol. 8: 161-187.
26. Mendez, R., Zheng, Z., Fan, Z., Rajagopalan, S., Sun, Q., and, Zhang, K. 2013. Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response, and lipid deposition in white adipose tissue. Am. J. Transl. Res. 5: 224-234.
27. Mossman, B. T., Lippmann, M., Heesterberg, T. W., Kelsey, K. T., Barchowsky, A., and, Bonner, J. C. 2011. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J. Toxicol. Environ. Health B 14: 76-121.
28. Noonan, C. W., Pfau, J. C., Larson, T. C., and, Spence, M. R. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health Perspect. 114: 1243-1247.
29. ODonnell, L. C., Druhan, L. J., and, Avalos, B. R. 2002. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. J. Leukocyte Biol. 72: 478-485.
30. Padilla-Carlin, D. J., Schladweiler, M. C., Shannahan, J. H., Kodavanti, U. P., Nyska, A., Burgoon, L. D., and, Gavett, S. H. 2011. Pulmonary inflammatory and fibrotic responses in Fischer 344 rats after intratracheal instillation exposure to Libby amphibole. J. Toxicol. Environ. Health A 74: 1111-1132.
31. Padmasekar, M., Nandigama, R., Wartenberg, M., Schlüter, K. D., and, Sauer, H. 2007. The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1, 2 and PI3-kinase/Akt pathways. Cardiovasc. Res. 75: 118-128.
32. Pantazopoulos, I., Boura, P., Xanthos, T., and, Syrigos, K. 2013. Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur. Respir. J. 41: 706-715.
33. Park, E. K., Thomas, P. S., Johnson, A. R., and, Yates, D. H. 2009. Osteopontin levels in an asbestos-exposed population. Clin. Cancer Res. 15: 1362-1366.
34. Park, S. K., Auchincloss, A. H., ONeill, M. S., Prineas, R., Correa, J. C., Keeler, J., Barr, R. G., Kaufman, J. D., and, Diez Roux, A. V. 2010. Particulate air pollution, metabolic syndrome, and heart rate variability: The multi-ethnic study of atherosclerosis (MESA). Environ. Health Perspect. 118: 1406-1411.
35. Pass, H. I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., and, Wali, A. 2005. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N. Engl. J. Med. 353: 1564-1573.
36. Rodríguez Portal, J. A. 2012. Asbestos-related disease: Screening and diagnosis. Adv. Clin. Chem. 57: 163-185.
37. Sabo-Attwood, T., Ramos-Nino, M. E., Eugenia-Ariza, M., Macpherson, M. B., Butnor, K. J., Vacek, P. C., McGee, S. P., Clark, J. C., Steele, C., and, Mossman, B. T. 2011. Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. Am. J. Pathol. 178: 1975-1985.
38. Salazar, K. D., Copeland, C. B., Wood, C. E., Schmid, J. E., and, Luebke, R. W. 2013. Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J. Immunotoxicol. 10: 329-333.
39. Shannahan, J. H., Nyska, A., Cesta, M., Schladweiler, M. C., Vallanat, B. D., Ward, W. O., Ghio, A. J., Gavett, S. H., and, Kodavanti, U. P. 2012a. Subchronic pulmonary pathology, iron-overload, and transcriptional activity after Libby amphibole exposure in rat models of cardiovascular disease. Environ. Health Perspect. 120: 85-91.
40. Shannahan, J. H., Alzate, O., Winnik, W. M., Andrews, D., Schladweiler, M. C., Ghio, A. J., Gavett, S. H., and, Kodavanti, U. P. 2012b. Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposure. Toxicol. Appl. Pharmacol. 260: 105-114.
41. Sun, Q., Yue, P., Deiuliis, J. A., Lumeng, C. N., Kampfrath, T., Mikolaj, M. B., Cai, Y., Ostrowski, M. C., Lu, B., Parthasarathy, S., Brook, R. D., Moffatt-Bruce, S. D., Chen, L. C., and and, Rajagopalan, S. 2009. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 119: 538-546.
42. Thomson, E. M., Vladisavljevic, D., Mohottalage, S., Kumarathasan, P., and, Vincent, R. 2013. Mapping acute systemic effects of inhaled particulate matter and ozone: Multiorgan gene expression and glucocorticoid activity. Toxicol. Sci. 135: 169-181.
43. Tsujimura, T., Torii, I., Sato, A., Song, M., Fukuoka, K., Hasegawa, S., and, Nakano, T. 2012. Pathological and molecular biological approaches to early mesothelioma. Int. J. Clin. Oncol. 17: 40-47.
44. Wyatt, A. R., Constantinescu, P., Ecroyd, H., Dobson, C. M., Wilson, M. R., Kumita, J. R., and, Yerbury, J. J. 2013. Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms. FEBS Lett. 587: 398-403.
45. Yin, Y., Pastrana, J. L., Li, X., Huang, X., Mallilankaraman, K., Choi, E. T., Madesh, M., Wang, H., and, Yang, X. F. 2013. Inflammasomes: Sensors of metabolic stresses for vascular inflammation. Front. Biosci. (Landmark Ed.) 18: 638-649.